Here is how major stock markets outside the United States ended on Monday.
Drug giant Roche lent support as it gained 2.4 percent to 129.25 Swiss francs after some positive late-stage data on its cancer drug, Tarceva. Dresdner Kleinwort Wasserstein raised its recommendation on Roche to "buy" from "add" and increased its price target to 149 francs.
The FTSE Eurotop 300 index of pan-European blue chips closed 0.4 percent lower at 997.7 points, erasing most of Friday's gains.
The benchmark S&P/ASX 200 index slipped 2.9 points or 0.08 percent to finish at 3,628.7.
The All-share index closed at 11459.78, down 53.48 points or 0.46 percent, the Gold index closed at 1974.1, down 18.49 points or 0.93 percent, while the Industrial index closed at 7968.55, down 13.96 points or 0.17 percent.
The Nikkei ended on Friday down 0.51 percent or 56.87 points to 11,082.49.